open access
Adenocarcinoma of the appendix — case study
Affiliations- Department of Oncology, Poznań University of Medical Sciences, Poznań, Poland, Poland
- Greater Poland Cancer Centre, Poznań, Poland
open access
Abstract
The following study presents the case of a 58-year-old woman who was diagnosed, during the diagnosis of an ovarian tumor, with mucous metastatic adenocarcinoma of the appendix. Due to the severity of the disease and the low degree of differentiation of the cancer, the treatment of the patient required a continuous and intensive systemic treatment lasting three years. A significant role in the course of the disease was also played by surgical interventions, since the patient underwent 4 reoperations due to local recurrence. The history of the disease is an example of the problems in the therapy and diagnosis of atypical tumors resulting from non-specific symptoms and different evolution of the disease.
Abstract
The following study presents the case of a 58-year-old woman who was diagnosed, during the diagnosis of an ovarian tumor, with mucous metastatic adenocarcinoma of the appendix. Due to the severity of the disease and the low degree of differentiation of the cancer, the treatment of the patient required a continuous and intensive systemic treatment lasting three years. A significant role in the course of the disease was also played by surgical interventions, since the patient underwent 4 reoperations due to local recurrence. The history of the disease is an example of the problems in the therapy and diagnosis of atypical tumors resulting from non-specific symptoms and different evolution of the disease.
Keywords
adenocarcinoma of the appendix, palliative surgery, chemotherapy, molecular therapy, regorafenib, quality of life
About this articleTitle
Adenocarcinoma of the appendix — case study
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Case report
Pages
486-489
Published online
2017-06-12
Page views
720
Article views/downloads
1304
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2016;66(6):486-489.
Keywords
adenocarcinoma of the appendix
palliative surgery
chemotherapy
molecular therapy
regorafenib
quality of life
Authors
Olga Milbrandt
Anna Szafryna-Kliwicka
Piotr Tomczak
Rodryg Ramlau